Infinity Stock Analysis

INFI -  USA Stock  

USD 1.11  0.07  5.93%

The big decline in price over the last few months for Infinity Pharmaceutimay raise some interest from stockholders. The stock closed today at a share price of 1.11 on 910,209 in trading volume. The company executives failed to add value to investors and positioning the firm supply of money to exploit market volatility in December. However, diversifying your holdings with Infinity Pharmaceuti or any similar stocks can still protect your portfolios during high-volatility market scenarios. The stock standard deviation of daily returns for 90 days investing horizon is currently 5.17. The very high volatility is mostly attributed to the latest market swings and not very good earnings reports from some of the Infinity Pharmaceuti partners.
Please see Risk vs Return Analysis.

Infinity Stock Analysis 

The Infinity Pharmaceuti stock analysis report makes it easy to digest most publicly released information about Infinity Pharmaceuti and get updates on important government artifacts, including earning estimates, SEC corporate filings, and announcements. Infinity Stock analysis module also helps to analyze the Infinity Pharmaceuti price relationship with some important fundamental indicators such as market cap and management efficiency.

Infinity Stock Analysis Notes

About 59.0% of the company shares are owned by institutional investors. The book value of Infinity Pharmaceuti was currently reported as 0.36. The company recorded a loss per share of 0.56. Infinity Pharmaceuti had not issued any dividends in recent years. The entity had 1:4 split on the 13th of September 2006. Infinity Pharmaceuticals, Inc., a biopharmaceutical company, focuses on developing novel medicines for people with cancer. Infinity Pharmaceuticals, Inc. was incorporated in 2000 and is headquartered in Cambridge, Massachusetts. Infinity Pharmaceuti operates under Biotechnology classification in the United States and is traded on NASDAQ Exchange. It employs 23 people. To learn more about Infinity Pharmaceuti call Adelene Perkins at 617 453-1000 or check out

Infinity Pharmaceuti Investment Alerts

Many investors view ongoing market volatility as an opportunity to purchase more stocks at a favorable price or short it to generate a bearish trend profit opportunity. If you are one of those investors, make sure you clearly understand the position you are entering. Infinity Pharmaceuti's investment alerts are automatically generated signals that are significant enough to either complement your investing judgment regarding Infinity Pharmaceuti or challenge it. These alerts can help you understand what you are buying and avoid costly mistakes.
Infinity Pharmaceuti generated a negative expected return over the last 90 days
Infinity Pharmaceuti has high historical volatility and very poor performance
Infinity Pharmaceuti may become a speculative penny stock
Infinity Pharmaceuti was previously known as Infinity Pharmaceuticals and was traded on NASDAQ Exchange under the symbol DPII.
The company reported the previous year's revenue of 1.84 M. Net Loss for the year was (44.21 M) with loss before overhead, payroll, taxes, and interest of (26.08 M).
Infinity Pharmaceuti currently holds about 90.09 M in cash with (39.41 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 1.01.
Infinity Pharmaceuti has a frail financial position based on the latest SEC disclosures
Roughly 59.0% of the company shares are owned by institutional investors
Latest headline from MacroaxisInsider: Acquisition by Ilaria Robert Jr of 87472 shares of Infinity Pharmaceuti subject to Rule 16b-3

Infinity Pharmaceuti Upcoming and Recent Events

Earnings reports are used by Infinity Pharmaceuti to provide an update of all three financial statements, including the income statement, the balance sheet, and the cash flow statement. Every quarterly earnings report provides investors with three things: an overview of sales, expenses, and net income for the most recent period. It also may provide a comparison to Infinity Pharmaceuti previous reporting period. The quarterly earnings reports are usually disseminated to the public via Form 10-Q, which is a legal document filed with the Securities and Exchange Commission every quarter.
Upcoming Quarterly Report15th of March 2022
Next Earnings Report12th of May 2022
Next Fiscal Quarter End31st of December 2021
Next Fiscal Year End15th of March 2022
Last Quarter Report30th of September 2021
Last Earning Announcement31st of December 2020

Infinity Largest EPS Surprises

Earnings surprises can significantly impact Infinity Pharmaceuti's stock price both in the short term and over time. Negative earnings surprises usually result in a price decline. However, it has been seen that positive earnings surprises lead to an immediate rise in a stock's price and a gradual increase over time. This is why we often hear news about some companies beating earning projections. Financial analysts spend a large amount of time predicting earnings per share (EPS) along with other important future indicators. Many analysts use forecasting models, management guidance, and additional fundamental information to derive an EPS estimate.
Fiscal Date
Estimated EPS
Reported EPS
View All Earnings Estimates

Infinity Pharmaceuti SEC Filings

SEC filings are important regulatory documents required of all public companies to provide to potential investors. Infinity Pharmaceuti prospectus issued under the guidelines of SEC is a legal declaration of facts and statements to ensure that Infinity Pharmaceuti investors are not misled. SEC filings are required by law to meet strict transparency standards and other important legal constraints. Although many companies may choose careful wording to disguise some material information, SEC filings make crucial Infinity Pharmaceuti specific information freely available to individual and institutional investors to make a timely investment decision.
18th of January 2022
Unclassified Corporate Event
5th of January 2022
Financial Statements and Exhibits. Other Events. Results of Operations and Financial Condition
10th of December 2021
Financial Statements and Exhibits. Other Events
2nd of November 2021
Financial Statements and Exhibits. Results of Operations and Financial Condition
7th of September 2021
Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
27th of July 2021
Financial Statements and Exhibits. Other Events. Regulation FD Disclosure. Results of Operations and Financial Condition
17th of June 2021
Unclassified Corporate Event
11th of June 2021
Submission of Matters to a Vote of Security Holders

Infinity Stock Institutional Investors

Have you ever been surprised when a price of an equity instrument such as Infinity Pharmaceuti is soaring high without any particular reason? This is usually happening because many institutional investors are aggressively trading Infinity Pharmaceuti backward and forwards among themselves. Infinity Pharmaceuti's institutional investor refers to the entity that pools money to purchase Infinity Pharmaceuti's securities or originate loans. Institutional investors include commercial and private banks, credit unions, insurance companies, pension funds, hedge funds, endowments, and mutual funds. Operating companies that invest excess capital in these types of assets may also be included in the term and may influence corporate governance by exercising voting rights in their investments.
Security TypeSharesValue
Callan Capital LlcCommon Shares146.2 K329 K
Russell Investments Group LtdCommon Shares37.9 K85 K
Cutler Group LpCommon Shares9.3 K20 K
National Bank Of CanadaCommon Shares2.6 KK
Koshinski Asset Management IncCommon SharesK4.5 K
Cutler Group LpPut Options7001000
Cutler Group LpCall Options3000.0
Tci Wealth Advisors IncCommon Shares2000.0
Bvf IncCommon Shares8.4 M28.7 M
Note, although Infinity Pharmaceuti's institutional investors appear to be way more sophisticated than retail investors, it remains unclear if professional active investment managers can reliably enhance risk-adjusted returns by an amount that exceeds fees and expenses.

Infinity Market Capitalization

The company currently falls under 'Small-Cap' category with current market capitalization of 105.04 M. Market capitalization usually refers to the total value of a company's stock within the entire market. To calculate Infinity Pharmaceuti's market, we take the total number of its shares issued and multiply it by Infinity Pharmaceuti's current market price. To manage market risk and economic uncertainty, many investors today build portfolios that are diversified across equities with different market capitalizations. However, as a general rule, conservative investors tend to hold large-cap stocks, and these looking for more risk prefer small-cap and mid-cap equities.

Infinity Profitablity

Infinity Pharmaceuti's profitability indicators refer to fundamental financial ratios that showcase Infinity Pharmaceuti's ability to generate income relative to its revenue or operating costs. If, let's say, Infinity Pharmaceuti is currently losing money, the management's focus should be on how to reverse that trend. However, when revenue exceeds expenses, Infinity Pharmaceuti's executives or investors may be in less hurry to break that information down - which is where profitability analysis comes into play. Gaining a greater understanding of Infinity Pharmaceuti's profitability requires more research than a typical breakdown of Infinity Pharmaceuti's financial statements. By doing a profitability analysis, companies can identify areas needing attention, and investors can make a profitable trade.
Last ReportedProjected for 2022
Return on Investment(174.51) (179.10) 
Return on Average Assets(0.76) (0.78) 
Return on Average Equity 3.67  3.96 
Return on Invested Capital(2.58) (2.65) 
Return on Sales(19.92) (20.44) 

Management Efficiency

The entity has return on total asset (ROA) of (38.68) % which means that it has lost $38.68 on every $100 spent on asset. This is way below average. Similarly, it shows return on stockholders equity (ROE) of (490.76) %, meaning that it created substantial loss on money invested by shareholders. Infinity Pharmaceuti management efficiency ratios could be used to measure how well infinity pharmaceuti manages its routine affairs as well as how well it operates its assets and liabilities. The current Return on Average Equity is estimated to increase to 3.96, while Return on Investment is projected to decrease to (179.10) . Infinity Pharmaceuti Assets Non Current are most likely to decrease significantly in the upcoming years. The last year's value of Assets Non Current was reported at 2.97 Million. The current Revenue to Assets is estimated to increase to 0.05, while Return on Average Assets are projected to decrease to (0.78) .
Last ReportedProjected for 2022
Book Value per Share(0.35) (0.36) 
Enterprise Value over EBIT(3.45) (3.72) 
Enterprise Value over EBITDA(3.65) (3.94) 
Price to Book Value(5.33) (5.47) 
Tangible Assets Book Value per Share 0.59  0.61 
Enterprise Value107.2 M110.1 M
Tangible Asset Value35.4 M36.3 M

Technical Drivers

As of the 28th of January, Infinity Pharmaceuti retains the risk adjusted performance of (0.17), and Market Risk Adjusted Performance of (0.59). Infinity Pharmaceuti technical analysis makes it possible for you to employ historical prices and volume momentum with the intention to determine a pattern that calculates the direction of the firm's future prices. Simply put, you can use this information to find out if the firm will indeed mirror its model of historical price patterns, or the prices will eventually revert. We were able to analyze and collect data for nineteen technical drivers for Infinity Pharmaceuti, which can be compared to its competitors. Please check out Infinity Pharmaceuti downside variance, kurtosis, as well as the relationship between the treynor ratio and standard deviation to decide if Infinity Pharmaceuti is priced fairly, providing market reflects its last-minute price of 1.11 per share. Given that Infinity Pharmaceuti is a hitting penny stock territory we urge to closely look at its total risk alpha.

Infinity Pharmaceuti Price Movement Analysis

The output start index for this execution was fourty-seven with a total number of output elements of fourteen. The Mid-point Price over period is an average of Infinity Pharmaceuti highest and lowest prices attained during the given period. View also all equity analysis or get more info about midpoint price over period overlap studies indicator.

Infinity Pharmaceuti Insider Trading Activities

Some recent studies suggest that insider trading raises the cost of capital for securities issuers and decreases overall economic growth. Trading by specific Infinity Pharmaceuti insiders, such as employees or executives, is commonly permitted as long as it does not rely on Infinity Pharmaceuti's material information that is not in the public domain. Local jurisdictions usually require such trading to be reported in order to monitor insider transactions. In many U.S. states, trading conducted by corporate officers, key employees, directors, or significant shareholders must be reported to the regulator or publicly disclosed, usually within a few business days of the trade. In these cases Infinity Pharmaceuti insiders are required to file a Form 4 with the U.S. Securities and Exchange Commission (SEC) when buying or selling shares of their own companies.
Ilaria Robert Jr over two weeks ago via Macroaxis 
Acquisition by Ilaria Robert Jr of 87472 shares of Infinity Pharmaceuti subject to Rule 16b-3
Schwartz Brian over three months ago via Macroaxis 
Acquisition by Schwartz Brian of 60000 shares of Infinity Pharmaceuti subject to Rule 16b-3
Ilaria Robert Jr over three months ago via Macroaxis 
Acquisition by Ilaria Robert Jr of 300000 shares of Infinity Pharmaceuti subject to Rule 16b-3
Peluso Stephane over three months ago via Macroaxis 
Acquisition by Peluso Stephane of 50000 shares of Infinity Pharmaceuti subject to Rule 16b-3
Samuel Agresta over six months ago via Macroaxis 
Acquisition by Samuel Agresta of 30000 shares of Infinity Pharmaceuti subject to Rule 16b-3
Norman Selby over six months ago via Macroaxis 
Exercise or conversion by Norman Selby of 5000 shares of Infinity Pharmaceuti subject to Rule 16b-3
Bvf Partners L P over six months ago via Macroaxis 
Infinity Pharmaceuti exotic insider transaction detected
Bvf Partners L P over six months ago via Macroaxis 
Sale by Bvf Partners L P of 152127 shares of Infinity Pharmaceuti
Bvf Partners L P over a year ago via Macroaxis 
Sale by Bvf Partners L P of 568019 shares of Infinity Pharmaceuticals
Tasker Seth A over a year ago via Macroaxis 
Acquisition by Tasker Seth A of 250000 shares of Infinity Pharmaceuticals subject to Rule 16b-3
Samuel Agresta over a year ago via Macroaxis 
Acquisition by Samuel Agresta of 30000 shares of Infinity Pharmaceuticals subject to Rule 16b-3
Rosebay Medical Co Lp over a year ago via Macroaxis 
Purchase by Rosebay Medical Co Lp of 1000000 shares of Infinity Pharmaceuticals

Infinity Pharmaceuti Predictive Daily Indicators

Infinity Pharmaceuti intraday indicators are useful technical analysis tools used by many experienced traders. Just like the conventional technical analysis, daily indicators help intraday investors to analyze the price movement with the timing of Infinity Pharmaceuti stock daily movement. By combining multiple daily indicators into a single trading strategy, you can limit your risk while still earning strong returns on your managed positions.

Infinity Pharmaceuti Forecast Models

Infinity Pharmaceuti time-series forecasting models is one of many Infinity Pharmaceuti's stock analysis techniquest aimed to predict future share value based on previously observed values. Time-series forecasting models ae widely used for non-stationary data. Non-stationary data are called the data whose statistical properties e.g. the mean and standard deviation are not constant over time but instead, these metrics vary over time. These non-stationary Infinity Pharmaceuti's historical data is usually called time-series. Some empirical experimentation suggests that the statistical forecasting models outperform the models based exclusively on fundamental analysis to predict the direction of the stock market movement and maximize returns from investment trading.

About Infinity Stock Analysis

Stock analysis is the technique used by a trader or investor to examine and evaluate how Infinity Pharmaceuti stock is reacting to, or reflecting on a current stock market direction and economic conditions. It can be used to make informed decisions about market timing, and when buying or selling Infinity shares will generate the highest return on investment. We also built our stock analysis module to help investors to gain an insight into the world economy as a whole, the stock market, thematic ideas, a specific sector, or an individual stock such as Infinity Pharmaceuti. By using and applying Infinity Stock analysis, traders can create a robust methodology for identifying Infinity entry and exit points for their positions.
Last ReportedProjected for 2022
Operating Margin(48.48) (52.31) 
EBITDA Margin(19.67) (20.18) 
Gross Margin 0.90  0.89 
Profit Margin(21.20) (21.76) 
Infinity Pharmaceuticals, Inc., a biopharmaceutical company, focuses on developing novel medicines for people with cancer. Infinity Pharmaceuticals, Inc. was incorporated in 2000 and is headquartered in Cambridge, Massachusetts. Infinity Pharmaceuti operates under Biotechnology classification in the United States and is traded on NASDAQ Exchange. It employs 23 people.

Current Infinity Analysis - Recommendations

We track the performance of the top 100 financial experts across various large and mid-size financial boutiques. Infinity analyst recommendations are determined by taking all analyst recommendations and averaging them as Strong Buy, Buy, Hold, Strong Sell or Sell. There is no one specific way to measure analysis performance other than comparing it to the past results via a very sophisticated attribution analysis. Infinity analyst consensus and target price projections should be used in combination with other traditional techniques such as stock price forecasting, technical analysis, earnings estimate, and various momentum models.
Target PriceAdvice# of Analysts
9.71Strong Buy7Odds
Infinity Pharmaceuti current and past analyst recommendations published by a number of research institutions as well as average analyst consensus.
Most Infinity analysts issue ratings four times a year, at intervals of three months. Ratings are usually accompanied by a target price to helps potential investors understand Infinity stock's fair price compared to its market value. Analysts arrive at stock ratings after researching public financial statements of Infinity Pharmaceuti, talking to its executives and customers, or listening to Infinity conference calls.
Infinity Analyst Advice Details

Infinity Stock Analysis Indicators

Infinity Pharmaceuti stock analysis indicators help investors evaluate how Infinity Pharmaceuti stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing and determine when trading Infinity Pharmaceuti shares will generate the highest return on investment. By understating and applying Infinity Pharmaceuti stock analysis, traders can identify Infinity Pharmaceuti position entry and exit signals to maximize returns.
Quick Ratio7.29
Fifty Two Week Low1.0600
Revenue Growth-13.70%
Shares Short Prior Month2.21M
Average Daily Volume Last 10 Day1.21M
Average Daily Volume In Three Month1.61M
Shares Percent Shares Out3.07%
Short Percent Of Float3.14%
Forward Price Earnings-2.03
Float Shares78.7M
Fifty Two Week High5.9800
Enterprise Value To Ebitda-2.40
Fifty Day Average2.0714
Two Hundred Day Average2.7928
Enterprise Value To Revenue56.55
Please see Risk vs Return Analysis. Note that the Infinity Pharmaceuti information on this page should be used as a complementary analysis to other Infinity Pharmaceuti's statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try Shere Portfolio module to track or share privately all of your investments from the convenience of any device.

Complementary Tools for Infinity Stock analysis

When running Infinity Pharmaceuti price analysis, check to measure Infinity Pharmaceuti's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Infinity Pharmaceuti is operating at the current time. Most of Infinity Pharmaceuti's value examination focuses on studying past and present price action to predict the probability of Infinity Pharmaceuti's future price movements. You can analyze the entity against its peers and financial market as a whole to determine factors that move Infinity Pharmaceuti's price. Additionally, you may evaluate how the addition of Infinity Pharmaceuti to your portfolios can decrease your overall portfolio volatility.
Probability Of Bankruptcy
Get analysis of equity chance of financial distress in the next 2 years
Idea Breakdown
Analyze constituents of all Macroaxis ideas. Macroaxis investment ideas are predefined, sector-focused investing themes
Idea Analyzer
Analyze all characteristics, volatility and risk-adjusted return of Macroaxis ideas
Portfolio Suggestion
Get suggestions outside of your existing asset allocation including your own model portfolios
Shere Portfolio
Track or share privately all of your investments from the convenience of any device
Headlines Timeline
Stay connected to all market stories and filter out noise. Drill down to analyze hype elasticity
Bollinger Bands
Use Bollinger Bands indicator to analyze target price for a given investing horizon
Crypto Correlations
Use cryptocurrency correlation module to diversify your cryptocurrency portfolio across multiple coins
Cryptocurrency Center
Build and monitor diversified portfolio of extremely risky digital assets and cryptocurrency
Insider Screener
Find insiders across different sectors to evaluate their impact on performance
Portfolio Optimization
Compute new portfolio that will generate highest expected return given your specified tolerance for risk
Is Infinity Pharmaceuti's industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Infinity Pharmaceuti. If investors know Infinity will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Infinity Pharmaceuti listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
The market value of Infinity Pharmaceuti is measured differently than its book value, which is the value of Infinity that is recorded on the company's balance sheet. Investors also form their own opinion of Infinity Pharmaceuti's value that differs from its market value or its book value, called intrinsic value, which is Infinity Pharmaceuti's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Infinity Pharmaceuti's market value can be influenced by many factors that don't directly affect Infinity Pharmaceuti's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Infinity Pharmaceuti's value and its price as these two are different measures arrived at by different means. Investors typically determine Infinity Pharmaceuti value by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Infinity Pharmaceuti's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.